Updated on 9 August 2012
The purpose of the BIG Scheme is to upscale and validate of proof of concept; encourage researchers to take technology closer to market through a start-up; and excite interest of potential licensees or investors.
Biotechnology Industry Partnership Programme (BIPP)
Biotechnology Industry Partnership Programme (BIPP) is a government partnership with Industries for support on a cost sharing basis for path-breaking research in frontier futuristic technology areas having major economic potential and making the Indian industry globally competitive. It is focused on IP creation with ownership retained by Indian industry and wherever relevant, by collaborating scientists.
BIPP supports the development of appropriate technologies in the context of recognized national priorities in the area of agriculture, health, bio-energy, green manufacturing, when the scale of the problem has serious consequences for social and economic development. BIPP is an advanced technology scheme only for high risk, transformational technology or process development. It is for high risk futuristic technologies and mainly for viability gap funding. The uniqueness of this scheme is that it is for "breakthrough research" that enables product and process development and is patentable, with IP ownership rights resting with industry.
Indian Biotech companies regulated under Indian Company Act 1956 with 51% Indian shareholding (including NRI's) who have DSIR recognized R&D are entitled for BIPP funding, either independently or in collaboration with companies, not for Profit organisation or academics partners.
So far 88 agreements have been signed with 72 companies involving aprrox. 50 startups and SMEs. Scheme provides for both soft loan and grant. A total of investment of US $ 141m has been committed with US $ 50m by Govt. of India with a matching contribution of US$ 91m coming in as private sector contribution.